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Abstract
Background: Nocardia infection is a rare but well-recognized side effect of immunosuppressive therapy in-
cluding tumor necrosis factor-a (TNF-a) antagonists. However, Nocardia colitis has only been previously
reported once in the English literature.
Case Report:We present a 58-y-old female with history of Crohn disease maintained on multiple medications
including infliximab (a TNF-a antagonist). The patient presented to the emergency department with hema-
tochezia and abdominal pain. Computed tomography (CT) scan revealed extensive pneumotosis throughout
the bowel as well as mesenteric and portal venous gas. She underwent an exploratory laparotomy that
revealed bowel edema without ischemia. No bowel was resected and at a planned second-look laparotomy
48 h later, the bowel appeared normal and the abdomen was closed. Post-operatively, the patient tested
negative for Clostridium difficile infection. The blood and abdominal fluid cultures were positive for No-
cardia farcinica.
Conclusion: The patient had a complicated post-operative course and developed multiple hospital-acquired
infections. However, she survived and was placed in sub-acute rehabilitation four weeks after the acute surgical
intervention.
We present the case of a patient with Nocardia colitisand disseminated nocardiosis. The 58-y-old female
patient had a past medical history significant for Crohn dis-
ease that had required multiple small bowel resections in
the distant past. At presentation, she was being maintained
on azathioprine, mesalamine, budesonide, and infliximab, a
tumor necrosis factor-a (TNF-a) antagonist. Four weeks
before presentation the patient had been hospitalized for
community-acquired pneumonia and was treated with a
course of intravenous antibiotics before being discharged
home with a course of oral antibiotics. After discharge, the
patient had several weeks of mild abdominal pain and un-
derwent an esophagogastroduodenoscopy (EGD) as an out-
patient that revealed no abnormalities. She subsequently
presented to the emergency department with hematochezia
and moderate bilateral lower quadrant abdominal pain.
Computed tomography (CT) scan performed at this time re-
vealed extensive pneumotosis in the wall of the distal small
bowel and entire colon as well as mesenteric and portal ve-
nous gas (Fig. 1).
A detailed laboratory evaluation revealed a significant
leukocytosis, lactic acidosis, and evidence of acute kidney
injury. After appropriate resuscitation, she was taken
emergently to the operating room for exploratory laparot-
omy. Intra-operatively, she was found to have to have mild
small bowel dilation and mild edema of the colon but no
evidence of transmural ischemia or inflammation. A flexi-
ble sigmoidoscopy was performed that revealed multiple
areas of ulceration and membranes consistent with pseu-
domembranous colitis. A presumed diagnosis of Clos-
tridium difficile colitis was made and no resection was
performed. She was admitted to the surgical intensive care
unit (ICU) with an ABThera (KCI USA, San Antonio,
TX) abdominal vacuum dressing in place. She was treated
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with broad spectrum antibiotics as well as triple antibiotic
therapy for C. difficile colitis (oral and rectal vancomycin
and intravenous metronidazole). The patient was taken
back to the operating room two days later for a planned
second-look laparotomy. The surface of the small and large
intestines appeared to have improved substantially from the
time of the initial laparotomy; the abdomen was irrigated
and the fascia was closed.
Post-operatively, the patient tested negative for C. difficile
infection. However, her blood and abdominal fluid cultures
were positive for Nocardia farcinica. On the basis of anti-
biotic sensitivity, imipenem-cilistatin, amikacin, and Bac-
trim (Hoffman-La Roche, Nutley, NJ) were added to her
antibiotic regimen. Her post-operative course was compli-
cated further by adrenal hemorrhage, diffuse pulmonary
hemorrhage, acute respiratory distress syndrome (ARDS),
and cytomegalovirus (CMV) viremia (although notably, her
CMV counts were less than 300 copies per milliliter). She
was found to be severely pancytopenic and a bone marrow
biopsy revealed maturation arrest consistent with Nocardia
infection. A subsequent flexible sigmoidoscopy on hospital
day 16 revealed ulcerated lesions throughout the visualized
colon that were biopsy negative for CMV. A repeat CT scan
revealed no evidence of small bowel or colon ischemia. After
a prolonged ICU admission, she was transitioned to a general
care floor and was discharged to sub-acute rehabilitation.
The patient presented again to our institution three weeks
after discharge with new onset right lower quadrant pain and
sepsis. Computed tomography scan again revealed pancolitis
with pneumatosis. Flexible sigmoidoscopy revealed edema-
tous, friable mucosa with ulcerations, and biopsies were
positive for severe CMV colitis. Cultures obtained by bron-
choscopy also revealed CMV pneumonia. She was initiated
on gancyclovir for treatment of CMV. After another pro-
longed ICU stay, she was eventually discharged back to sub-
acute rehabilitation. After discharge, she was treated with a
four-month course of oral valgancyclovir for CMV and a one-
year course of Bactrim for Nocardia.
Conclusion
We describe an unusual case of secondary infection with
Nocardia in a patient who had been treated with a TNF-a
antagonist for Crohn’s disease. Nocardia infection is a rare
but well-recognized side effect of tumor necrosis factor an-
tagonists [1]. Furthermore, infection with Nocardia farcinica
is also rare [2,3]. The presentation of Nocardia colitis ob-
served in this patient is unusual and there has only been one
FIG. 1. Computed tomography (CT) scan obtained at the time of initial admission to the hospital revealed extensive
pneumatosis along the wall of the distal small bowel and colon. Additional areas of mesenteric and portal venous gas were
visualized.
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case documented previously in the literature [4]. This case
illustrates that patients being treated with TNF-a antagonists
are susceptible to infections by atypical organisms. Patients
with inflammatory bowel disease are often treated with
multiple immunosuppressive medications and may be at risk
for unusual infections, which should be included in the dif-
ferential diagnosis when caring for this population.
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ARDS¼ acute respiratory distress syndrome
CMV¼ cytomegalovirus
CT¼ computed tomography
EGD¼ esophagogastroduodenoscopy
ICU¼ intensive care unit
TNF-a¼ tumor necrosis factor-a
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